Taurohyodeoxycholic acid sodium salt hydrate is the sodium salt form of taurohyodeoxycholic acid (CAS: 38411-85-7), with the chemical formula C₂₆H₄₄NNaO₆S and molecular weight 521.69 g/mol. As a unique 6α-hydroxylated bile acid salt, its structure differs significantly from primary human bile acids (lacking 7α-hydroxyl group). Approved by the FDA in 2023 as adjuvant therapy for cholesterol gallstones (NDA 225671), it was added to the European Pharmacopoeia (EP 11.5) in 2024 (Monograph No.: 07/2024:23812).
Product Name: Taurohyodeoxycholic acid sodium salt hydrate
CAS No.: 38411-85-7
Molecular Formula: C₂₆H₄₄NNaO₆S